Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fibrinogen beta Chain Antikörper (AA 30-300)

FGB Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1F9 unconjugated
Produktnummer ABIN969136
  • Target Alle Fibrinogen beta Chain (FGB) Antikörper anzeigen
    Fibrinogen beta Chain (FGB)
    Bindungsspezifität
    • 9
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 30-300
    Reaktivität
    • 55
    • 17
    • 12
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 55
    • 13
    • 1
    Maus
    Klonalität
    • 56
    • 13
    Monoklonal
    Konjugat
    • 36
    • 12
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser Fibrinogen beta Chain Antikörper ist unkonjugiert
    Applikation
    • 50
    • 26
    • 21
    • 12
    • 9
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA
    Verwendungszweck
    FGB Antibody
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of human FGB (aa30-300) expressed in E. Coli.
    Klon
    1F9
    Isotyp
    IgG1
    Top Product
    Discover our top product FGB Primärantikörper
  • Applikationshinweise
    ELISA: 1/10000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Koch, Hoppmann, Biele, Mueller, Schömig, Kastrati: "Fibrinogen genes and myocardial infarction: a haplotype analysis." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 4, pp. 758-63, (2008) (PubMed).

    Vu, Bolton-Maggs, Parr, Morris, de Moerloose, Neerman-Arbez: "Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion." in: Blood, Vol. 102, Issue 13, pp. 4413-5, (2003) (PubMed).

  • Target
    Fibrinogen beta Chain (FGB)
    Andere Bezeichnung
    FGB (FGB Produkte)
    Synonyme
    FGB antikoerper, 2510049G14Rik antikoerper, DKFZp470D0312 antikoerper, LOC100223598 antikoerper, fibrinogen antikoerper, Ab1-216 antikoerper, Ac1-581 antikoerper, wu:fa55c11 antikoerper, zgc:77116 antikoerper, fgb antikoerper, fibrinogen beta chain antikoerper, fibrinogen beta chain L homeolog antikoerper, FGB antikoerper, Fgb antikoerper, fgb antikoerper, fgb.L antikoerper
    Hintergrund

    Description: Fibrinogen beta chain, also known as FGB, is a gene found in humans and most other vertebrates with a similar system of blood coagulation.It is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency.

    Aliases: fibrinogen beta chain

    Molekulargewicht
    52kDa
    Gen-ID
    2244
    HGNC
    2244
    UniProt
    P02675
Sie sind hier:
Kundenservice